Sermoreline

Sermoreline

Synthetic research peptide derived from GHRH (Growth Hormone Releasing Hormone), acting as a secretagogue, studied for stimulation of the hypothalamic-pituitary axis and endogenous release of growth hormone.

Available in France as high purity lyophilized powder (≥ 98%), in 5 mg and 10 mg vials, intended exclusively for research.

Product intended exclusively for laboratory research. Not intended for human or animal consumption.

Description & mode of action of Sermorelin

Sermorelin is a synthetic peptide derived from growth hormone-releasing hormone (GHRH ). Designed to mimic the 29-amino-acid active fragment of GHRH, it acts as a secretagogue , studied for its role in stimulating growth hormone production by the pituitary gland .

Sermorelin is not a growth hormone per se: in the models studied, it binds to specific pituitary receptors to trigger the endogenous release of human growth hormone (hGH). This mechanism physiologically mimics the natural activity of GHRH, promoting a hormonal release profile closer to physiological than the direct administration of exogenous growth hormone.